Aspen Pharmacare Holdings Ltd (APN) — Cash Flow Reinvestment Rate
Aspen Pharmacare Holdings Ltd (APN) has a Cash Flow Reinvestment Rate of 0.41x as of June 2025, reinvesting ZAC1.38 Billion (capex ZAC1.38 Billion ) from operating cash flow of ZAC3.35 Billion. Explore capital reinvestment ratio of Aspen Pharmacare Holdings Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Aspen Pharmacare Holdings Ltd Cash Flow Reinvestment Rate (2003–2025)
Historical reinvestment intensity for Aspen Pharmacare Holdings Ltd across 23 annual periods. Also explore Aspen Pharmacare Holdings Ltd balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Aspen Pharmacare Holdings Ltd (2003–2025)
Year-by-year capital reinvestment analysis for Aspen Pharmacare Holdings Ltd. For live market cap and broader valuation context, see market cap of Aspen Pharmacare Holdings Ltd.
| Year | Reinvestment Rate | Total Reinvested (ZAC) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.99x | ZAC10.27 Billion | ZAC5.16 Billion | ZAC5.05 Billion | ▼ -17.4% |
| 2024 | 2.41x | ZAC15.00 Billion | ZAC6.22 Billion | ZAC5.54 Billion | ▲ +101.5% |
| 2023 | 1.20x | ZAC6.60 Billion | ZAC5.52 Billion | ZAC3.18 Billion | ▲ +32.3% |
| 2022 | 0.90x | ZAC4.86 Billion | ZAC5.37 Billion | ZAC2.70 Billion | ▼ -53.2% |
| 2021 | 1.93x | ZAC13.19 Billion | ZAC6.83 Billion | ZAC3.43 Billion | ▲ +270.1% |
| 2020 | 0.52x | ZAC4.31 Billion | ZAC8.26 Billion | ZAC2.69 Billion | ▼ -54.0% |
| 2019 | 1.14x | ZAC6.82 Billion | ZAC6.00 Billion | ZAC3.58 Billion | ▼ -62.1% |
| 2018 | 3.00x | ZAC21.04 Billion | ZAC7.02 Billion | ZAC8.23 Billion | ▲ +634.9% |
| 2017 | 0.41x | ZAC2.65 Billion | ZAC6.50 Billion | ZAC2.60 Billion | ▼ -66.5% |
| 2016 | 1.22x | ZAC3.90 Billion | ZAC3.20 Billion | ZAC2.80 Billion | ▲ +125.3% |
| 2015 | 0.54x | ZAC2.62 Billion | ZAC4.84 Billion | ZAC2.42 Billion | ▼ -6.9% |
| 2014 | 0.58x | ZAC2.23 Billion | ZAC3.84 Billion | ZAC2.03 Billion | ▼ -46.4% |
| 2013 | 1.08x | ZAC4.32 Billion | ZAC3.99 Billion | ZAC4.32 Billion | ▲ +20.4% |
| 2012 | 0.90x | ZAC2.62 Billion | ZAC2.91 Billion | ZAC2.62 Billion | ▲ +162.1% |
| 2011 | 0.34x | ZAC840.20 Million | ZAC2.45 Billion | ZAC840.20 Million | ▼ -46.0% |
| 2010 | 0.64x | ZAC1.29 Billion | ZAC2.03 Billion | ZAC1.29 Billion | ▼ -79.0% |
| 2009 | 3.02x | ZAC3.91 Billion | ZAC1.29 Billion | ZAC3.91 Billion | ▲ +261.7% |
| 2008 | 0.84x | ZAC545.32 Million | ZAC652.38 Million | ZAC545.32 Million | ▲ +37.1% |
| 2007 | 0.61x | ZAC431.95 Million | ZAC708.56 Million | ZAC431.95 Million | ▼ -20.1% |
| 2006 | 0.76x | ZAC307.02 Million | ZAC402.21 Million | ZAC307.02 Million | ▲ +191.2% |
| 2005 | 0.26x | ZAC167.26 Million | ZAC638.20 Million | ZAC167.26 Million | ▼ -45.0% |
| 2004 | 0.48x | ZAC237.75 Million | ZAC498.74 Million | ZAC237.75 Million | ▼ -29.6% |
| 2003 | 0.68x | ZAC261.27 Million | ZAC385.95 Million | ZAC261.27 Million | — |